Reactivation of latent HIV using recombinant galectin-9
Location(s): United States
The research outlined in this Pilot Award is based on my previous work focusing on the relationship between host cell-intrinsic factors and HIV latency. There is tremendous interest in developing a cure for HIV, and this award will yield valuable insights into the usage of the human protein “galectin-9” as a foundation for novel HIV eradication strategies. It will also set the stage for the more broad-scale analyses of the curative potential of intrinsic immunity-based strategies in larger grant applications.